Magnetar Capital
Hedge fund
Active
Evanston, United States
32
461M
20
1.68
5
0.38
4
- Areas of investment
Summary
Magnetar Capital appeared to be the VC, which was created in 2005. The company was established in North America in United States. The main department of described VC is located in the Evanston.
Deals in the range of 50 - 100 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2016. Despite it in 2019 the fund had an activity. Opposing the other organizations, this Magnetar Capital works on 4 percentage points less the average amount of lead investments. The increased amount of exits for fund were in 2003. The real fund results show that this VC is 5 percentage points more often commits exit comparing to other companies.
Besides them, we counted 2 critical employees of this fund in our database.
The fund has no exact preference in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most successful fund investment fields, there are Medical Device, Life Science. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight SurgRx, Inc, Fountainhead Commercial Capital, Kintera.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Magnetar Capital, startups are often financed by Wells Fargo Securities, California Technology Ventures, Cadence Bancorp. The meaningful sponsors for the fund in investment in the same round are Wanxiang Healthcare Investments, WS Investments, Trellis Health Ventures. In the next rounds fund is usually obtained by Prospect Venture Partners, New Enterprise Associates, Alta Partners.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 32
- Lead investments
- 5
- Exits
- 4
- Rounds per year
- 1.68
- Follow on index
- 0.38
- Investments by industry
- Machine Learning (13)
- Information Technology (12)
- Cloud Computing (10)
- Infrastructure (10)
- Biotechnology (5) Show 47 more
- Investments by region
-
- United States (30)
- Australia (2)
- Peak activity year
- 2021
- Number of Unicorns
- 3
- Number of Decacorns
- 4
- Number of Minotaurs
- 3
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Avg. valuation at time of investment
- 1B
- Group Appearance index
- 0.75
- Strategy success index
- 0.70
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| CoreWeave | 01 May 2024 | Infrastructure, Information Technology, Machine Learning, Cloud Computing | Late Stage Venture | 1B | United States, New York, New York |
| Imvax | 10 Sep 2019 | Biotechnology, Pharmaceutical, Therapeutics | Early Stage Venture | 40M | United States, Pennsylvania, Philadelphia |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.